ࡱ> QSPY;#bjbjWW*L==- ]8888888LLLL8dL  . . . m m m ^``````$ X-8m i m m m Y88. . ; YYYm 8. 8. ^LL8888m ^YY Z88^. r LLC*4 Preliminary Program 1. GenomicsWilhelm Ansorge, EMBL, Heidelberg, Germany HUMAN GENOME CHIP IN BIOMEDICAL APPLICATIONSVladimir Tumanyan, Institute of Molecular Biology of Rus. Acad. Sci., Moscow, Russia SNPs AND HUMAN DISEASESDennis A. Gilbert, Advanced Research and Technology, Applied Biosystems, USA AWAITEDSteven Kelly, University of Wales, UK UNDERSTANDING YEAST STEROL BIOSYNTHESIS; DRUG TARGETS AND CONTROLRolf Schmid, Institute for Technical Biochemistry, University of Stuttgart, Germany MICROARRAYS FOR THE RAPID DIAGNOSIS OF ANTIBIOTICS IN A CLINICAL ENVIRONMENTPierre S. Paroutaud, Applera, France AWAITEDMikhail Gelfand, Institute of Problems for Information Transmission of Rus. Acad. Sci, Moscow, Russia COMPARATIVE GENOMICS OF BACTERIAL REGULATORY SYSTEMS AS THE BASIS FOR CREATION OF NEW MEDICINESNikolay Kolchanov, Institute of Cytology and Genetics of Rus. Acad. Sci., Novosibirsk, Russia AN INTEGRATED COMPUTER SYSTEM FOR STUDING THE REGULATION OF EUCARYOTIC GENE EXPRESSIONOlga V. Petrauskene, Applied Biosystems, USA AWAITED2. ProteomicsSamir Hanash, University of Michigan, Ann Arbor, USA. FUNCTIONAL PATHWAY ANALYSIS IN CANCER USING INTEGRATED GENOMICS AND PROTEOMICS.Jan Humphery-Smith, University of Utrecht, The Netherlands. THE ENTIRE HUMAN PROTEOME AND ITS RELEVANCE TO THE ESTABLISHMENT OF 'SELF' AND 'NON-SELF' DURING LYMPHOCYTE ONTOGENY.Andrey Shevchenko, Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, Germany. MULTIORGANISMAL PERSPECTIVE IN FUNCTIONAL PROTEOMICS.Claudio Nicolini, University of Genova and Fondazione Elba, Rome, Italy NEW AVENUES IN STRUCTURAL PROTEOMICS.Fuchu He, Beijing Institute of Radiation Medicine, China. PROTEOME AND INTEGRATION WITH ITS TRANSCRIPTOME OF HUMAN FETAL LIVER.Andrey Lisitsa, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia REVERSE ENGINEERING OF PROTEIN RELATIONSHIPS ON THE BASICS OF 2D-PAGE DATAYoung-Ki Paik, Yonsei Proteome Research Center & Biomedical Proteome Research Center, Korea. PROTEOMIC ANALYSIS OF CHOLESTEROL METABOLISM IN NEMATODES.3. BioinformaticsRolf Apweiler, European Bioinformatics Institute (EBI), Hinxton, Cambridge, UK. STANDARDISATION AND INTEGRATION: DRIVING FORCES IN BIOINFORMATICS FOR PROTEOMICS AND GENOMICSPeter Schuster, Institut fuer Theoretische Chemie und Molekulare Strukturbiologie der Universitaet Wien, Wien, Austria RNA - A MAGIC MOLECULE AT THE INTERPLAY OF STRUCTURAL BIOLOGY, BIOINFORMATICS, AND EVOLUTIONMarc Nicklaus, NIH/NCI, Frederick, MD, USA. NEW IDENTIFIERS AND TOOLS IN CHEMOINFORMATICSPaul Lewi, Center for Molecular Design, Beerse, Belgium TEN YEARS OF COMPUTER-AIDED DESIGN OF HIV1-REVERSE TRANSCRIPTASE INHIBITORS. HOW FAR DID WE GO?Eugene Shakhnovich, Harvard University, Cambridge, MA, USA AWAITEDSergey Varfolomeev, Chemistry Department of Moscow State University, Moscow, Russia BIOINFORMATICS AND CHEMISTRY OF ENZYMATIC CATALYTICAL CYCLEKyoung Tai No, Computer Aided Molecular Design Research Center, Seoul, Korea IN SILICO PREDICTION OF ABSORPTION, METABOLISM AND TOXICITYVladimir Poroikov, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia ALLIANCE OF BIO- AND CHEMOINFORMATICS IN COMPUTER-AIDED DRUG DISCOVERYSPECIAL WORKSHOPS:4.1. PeptidomicsPer Anden, Uppsala University, Sweden. A PEPTIDOMICS APPROACH OF EXPERIMENTAL PARKINSON'S DISEASE.Peter Schulz-Knappe, BioVisioN AG, Hannover, Germany. PEPTIDOMICS: BIOMARKER DISCOVERY IN BODY FLUIDS AND TISSUES.Vadim Ivanov, Institute of Bioorganic Chemistry of Rus. Acad. Sci., Moscow, Russia PEPTIDOMICS AS A NEW BRANCH OF POSGENOMIC TECHNOLOGIES4.2. Cytochromes P450 superfamilyJulian Peterson, UT Southwestern Medical Center, USA. USING SEQUENCE ANALYSIS TO RATIONALLY REDESIGN A P450. Alexis Ivanov, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia TRENDS AND NEW PERSPECTIVES IN 3D MODELLING OF CYTOCHROMES P450Rita Bernhardt, Universitaet des Saarlandes, Saarbrucken, Germany. NEW INSIGHTS INTO STRUCTURE AND FUNCTION OF STEROID HYDROXYLASES AND POTENTIAL APPLICATION IN MEDICINE.Victor Zgoda, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia EFFECT OF P450 INDUCERS ON MOUSE LIVER PROTEOMEVictoria Shumjantseva, Institute of Biomedical Chemistry of Rus.Acad. Med.Sci., Moscow, Russia ARTIFICIAL CATALYTIC CYCLE OF CYTOCHROME P450: APPLICATION FOR ELECTROCHEMICAL SYSTEMSSergey Usanov, Institute of Bioorganic Chemistry, National Academy of Sciences, Belarus GENOMICS AND PROTEOMICS OF STEROIDOGENESISSemen Gusev, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia CYTOCHROME P450 KNOWLEDGEBASE: INTEGRATING THE HETEROGENOUS DATA AND METHODSVyacheslav Lyakhovich, AWAITEDJohn Richards, California Institute of Technology CYTOCHROME P450, MECHANISM OF ACTION4.3. ISTC Special SessionNetessov S.V., Vector. The Study of Prevalence, Genotype Distribution and/ Molecular Variability of Isolates of Hepatitis C virus in the Siberian Part of Russia, Project N 1637Gabibov .., Institute of Bioorganic Chemistry Catalytic Antibody Approach in Development of New Antiviral Therapeutics, Project N 2226Poroikov V.V. State Research Institute of Organic Chemistry and Technology; Institute of Biomedical Chemistry RAMS Delayed Neurotoxicity, Early Diagnostics and Non-Experimental Forecasting, Project N 0574Sokolov N.N., Institute of Biomedical Chemistry RAMS Development of a new antitumoral drug of recombinant Erwinia Carotovora L-Asparaginase: results and prospects of research, Project N 1263 and N 2828.Varfolomeev S., Moscow State University Immunobiosensors based on magnetoresistance technology, Project N 15484.4. Emerging technologies Seminar HUPO4.4.1. Mass-Spectrometry in Biomedical ChemistryPeter J. Derrick, University of Warwick, Coventry, UK EMERGING TECHNOLOGIES FOR PROTEOMICS BASED ON MASS SPECTROMETRY.John B. Fenn, Virginia Commonwealth University, USA ELECTROSPRAY WINGS FOR MOLECULAR ELEFANTSHerbert Thiele, Bruker Daltonik GmbH, Bremen, Germany MASS SPECTROMETRY AND BIOINFORMATICS IN PROTEOMICSEmilio Gelpi, Instituto de Investigaciones Biomedicas de Barcelona, Spain REVISITING OLD HEALTH PROBLEMS WITH PROTEIN BIOMARKERSRichard Simpson, Ludwig Institute of Cancer Research, Parkville, Australia PROTEOMIC ANALYSIS OF COLORECTAL CANCER: STRATEGIES FOR NOVEL BIOMARKER DISCOVERYEvgeni Nikolaev, Institute of Energy Problems of Chemical Physics of Rus. Acad. Sci., Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia POTENTIALS AND PROBLEMS OF FTICR MS APPLICATIONS IN PROTEOMICSRon M. Heeren, FOM-Institute for Atomic and Molecular Physics, The Netherlands Direct mass spectrometric images of cells and tissues: A new ion microscope. 4.4.2. NanobiotechnologiesYoshinobu Baba, Faculty of Pharmaceutical Sciences, The University of Tokushima, Japan. NANO-BIODEVICE FOR GENOMIC MEDICINE AND SYSTEMS BIOLOGYDamian Twerenbold, Institute de Physique, Neuchatel, Switzerland. SENSITIVITY ISSUES IN SAMPLE PREPARATION, ANALYSIS AND INTERPRETATION. Yuri Ivanov, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia OPTICAL BIOSENSOR STUDY OF COMPLEX FORMATION IN PROTEOMICSVictor Bykov, NT-MDT, Moscow, Russia Development of scanning probe technique for molecular resolution researchAlexander Archakov , Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia AFM NANOTECHNOLOGIES IN PROTEOMICSMichael Kowalchuk, Institute of Crystallography of Rus. Acad. Sci., Moscow, Russia NANOBIOORGANIC MATERIALS  PAGE 2 &FGSTJK8H " # $    X l    PR1MN`ac 56CJ6CJ CJOJQJ5CJCJCJCJ5CJ CJOJQJ jCJUP&'(S8h\ $$l0'&P'!$$!$ $$l0 '/ d<$d<$ $d<$&'(S>FGHnSTUzJKL089:HIJ " # $ m    r  X Y Z l m n    "PQR  !   ^>FGHnSTUzJKL0ڨڌڼ  $$l0'&P'!$089:HIJ " # $ m @$p d$ $!$$ $$l0'&P'!$    r  X Y Z l m n    "ڜlPXt $!$$d$ $$l0'&P'!$"PQR'/01MNOhH0ژ $ $$l0'&P'!$'/01MNO  ELsabcL()*#$HIJKefg024DFHJqrs      ! ]  ELTL0 $ $$l0'&P'!$$!$!$$l40'&P'sabcLlظ(!$ $ $$l0'&P'!$$L(*$HIJKe04DFJqrt?@BQRTtvTUW 1!2!!!!6"8"""(#-#.#4#5#6#7#:#;#0JmH0J j0JUCJmH  CJOJQJ 5B* CJ5B* CJmH  56CJCJ5CJ 5CJmH K()*$IJKefg024FHژڈdp,<!$$ $ $$l0'&P'!$HJrst@ABjF8ըՀ $$ !$ $ $$l0'&P'!$ $st?@ABjFRST"tuvUVW   1!2!3!!!!!!6"7"8"""""#(#)#*#+#,#-#5#6#8#9#:#;#!   RRST"tuvUVWڬ |ڄ|td$ $ $$l0'&P'!$   l 1!2!3!!!!!!6"7"8"L4P $!$$l40'&P' $$l0'&P'!$$!$8"""""#(#)#*#+#,#-#8#9#:#;#ڸ $d $$l0'P' $ $$l0'&P'!$(&P . A!n"n#7$7%7 XDd B  S A?b=E԰2NK8Dvn=E԰2NK8PNG  IHDRu<^sRGBPLTE """)))UUUMMMBBB999|PP֭3f333f3333f3ffffff3f̙3ff333f333333333f33333333f33f3ff3f3f3f3333f33̙33333f333333f3333f3ffffff3f33ff3f3f3f3fff3ffffffffff3ffff̙fff3fffff3fff333f3f3ff3ff33f̙̙3̙ff̙̙̙3f̙3f̙333f3̙333f3ffffff3f̙̙3f̙3f3f333f3333f3fff̙fff3f̙3f3f̙fffffffff!___www˲𠠤X"N 3IDATx^=v8ufRld/sM^+…*wQ }A4H?i^Popu>v;TΙB8[LHDԊ şv f#D`bg@.a{W*KV8x`P*ꁛ ?aO ]6erLED~k"TY S%H (!N^@5KVNFɫfZ*Arl AVDcT0޴\mjZ$Xy"(&;Ds4'Z-AMOi?9dHOFEm/i/%Yș1kix4gK;_ס9è46$`7׉stդK*k 5Yb?vH˯LKp&p_z2_5Mt0#d~(r[cK=0TItU:go$~L,vjN6Y"he3VeĭAdzxr?eaS0 ;ҵm{-G+5" A@&ؘc( `cyɶ 2gd)Y8 KBNf4u(xMTkÅ5J Pۑm=á/ w\4c;m Yaɟpa?0@lHmw% djd&tH؉sERF#5dA3*8}H!{>o^P:oXĩEZFJ{) MF.hޟd&ѹoNuv1%>91U^<'#.?zF07;wTϜ-d)- H/o:fr`į?c-G(d;rb6=93 f m8k%ĆX۰WA: Wpt"RO±v(PB3-E$H& oqk7ɜ9;W eg3w3!t7̙ uU;A]ƀiGؤ> $Ij\2+黂+E, *f >w.oɣ4B(*@y:zqe#D9j.U+ !rEکw٨Yt_Oe1:GS*ֻXJX_u2ϊEM_1bFHo]XoE6F,ϴHU+cid?^2۸?*RЈgL]PNu1߂8,$,.}kAtĽˌ)lFfNã;-RT1A{\1>.)hޙ%AI?>I2Πh<`dJ['W<,;|]iQWҷ74l`JgI=4R+Ϫȿ UCIENDB`" [<@< 1KG=K9dhCJ_HmH sH tHH@H 03>;>2>: 1$$@&a$5>*CJOJQJDD 03>;>2>: 2$$@&a$5mH sH u>> 03>;>2>: 3$$@&a$5CJLL 03>;>2>: 4$d<@&56CJOJQJJJ 03>;>2>: 5$d<@&5CJOJQJZZ 03>;>2>: 6$$d<@&a$5CJOJQJmH sH uLL 03>;>2>: 7$d<@&56CJOJQJJJ 03>;>2>: 8$d<@&5CJOJQJ:A@: A=>2=>9 H@8DB 0170F0ZZ Workshop 01$xa$"5CJOJQJRHmHsHtH u<Q< A=>2=>9 B5:AB 3xCJD0D 0@:8@>20==K9 A?8A>:  & FH6"H 0@:8@>20==K9 A?8A>: 2  & FH72H 0@:8@>20==K9 A?8A>: 3  & FH8BH 0@:8@>20==K9 A?8A>: 4  & FH9RH 0@:8@>20==K9 A?8A>: 5  & FB1bB C<5@>20==K9 A?8A>:  & FF:rF C<5@>20==K9 A?8A>: 2  & FF;F C<5@>20==K9 A?8A>: 3  & FF<F C<5@>20==K9 A?8A>: 4  & F F=F C<5@>20==K9 A?8A>: 5  & F B>B 0720=85$da$5mH sH tH uDD 5@E=89 :>;>=B8BC;  9r B @B 86=89 :>;>=B8BC;  9r ,)@, ><5@ AB@0=8FKN"N 0720=85 >1J5:B0 $Xa$CJ&mH sH uPOP Prel-Program-1 (CJOJQJ_HmH sH tH4O4 Prel-Program-2!5;L ;#0 "H8";# !#$%s;#" !/X2$wlOYoA%kb$=E԰2NK8@0( Pd B S  ?;07_hLST] JOPVtyDJOY s{/ 7 8 < = I U _ ` p q t u  ] c z  X `   ! & ( / jo)13:05go! -t{[`bko~v|}^d-9<-9<ASI3D:\conferences\2002\GPBM2002\2nd-ann\Program-v6.docASI3D:\conferences\2002\GPBM2002\2nd-ann\Program-v6.docASI3C:\WINDOWS\TEMP\AutoRecovery save of Program-v6.asdASI3C:\WINDOWS\TEMP\AutoRecovery save of Program-v6.asd Alexis Ivanov4D:\conferences\2004\GPBM-2004\2nd_ann\Program-v1.doc Alexis Ivanov4D:\conferences\2004\GPBM-2004\2nd_ann\Program-v2.doc Alexis Ivanov4D:\conferences\2004\GPBM-2004\2nd_ann\Program-v2.docUser261AC:\>8 4>:C<5=BK\A2\>8 4>:C<5=BK\>=D5@5=F8O 2004\Program-v2.docUser261(C:\WINDOWS\TEMP\2B>:>?8O Program-v2.asdUser261(C:\WINDOWS\TEMP\2B>:>?8O Program-v2.asd|^B}"KA~TmP@P8>?ΐ8>d7Da6"5>`4n 8_   88Nư* %kG3 u4D EH$[7Z6T z\|x!DK5b >ck +bTu8Nư^`.^`.^`.^`. ^`OJQJo( ^`OJQJo( ^`OJQJo( ^`OJQJo(hh^h`. hh^h`OJQJo(hh^h`. hh^h`OJQJo(hh^h`CJ OJQJo(qhh^h`.hh^h`o(()hh^h`CJOJQJo(q hh^h`OJQJo(hh^h`B*OJQJo( hh^h`OJQJo(hh^h`o(. hh^h`OJQJo( hh^h`OJQJo(hh^h`CJ OJQJo(q~}|>ck7Z6TG3 8n DK5bu4D+bTu8_ z\*%EH@ ,)\q* '(;P@PP4@G:Times New Roman5Symbol3& :Arial;Wingdings"qh/Tf/ ] 5#r0d June 22, 2002ASIUser261 Oh+'0l   ( 4 @LT\dJune 22, 2002ouneASISINormal,User26110rMicrosoft Word 8.0@zT@( @E)@ ] ՜.+,D՜.+,@ hp  ,5 j June 22, 2002   6> _PID_GUIDAN{F8993E42-72B1-11D8-A01B-00902785B81D}  !"#$%&()*+,-.0123456789:;<=>?ABCDEFGIJKLMNORRoot Entry F 2r TData '1Table/ WordDocument*LSummaryInformation(@DocumentSummaryInformation8HCompObjjObjectPoolr r   F Microsoft Word MSWordDocWord.Document.89q